Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 2OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 15Thoracic 5NET 4Genitourinary 3Gastrointestinal 3Dermatologic 3CNS 3Head & Neck 2Sarcoma 1Other 1Breast 1

Conditions

Sarcoma 960Glioblastoma 299Gliosarcoma 288Osteosarcoma 286Brain Neoplasms 195Dendritic Cell Sarcoma, Interdigitating 188Gastrointestinal Stromal Tumors 180Bone Neoplasms 172Lymphoma 161Central Nervous System Neoplasms 160Astrocytoma 155Sarcoma, Ewing 151Glioma 149Precursor Cell Lymphoblastic Leukemia-Lymphoma 147Lymphoma, Non-Hodgkin 143Burkitt Lymphoma 139Neoplasms 137Recurrence 134Lymphoma, Large B-Cell, Diffuse 128Lymphoma, Follicular 128Rhabdomyosarcoma 126Neuroblastoma 126Hodgkin Disease 124Oligodendroglioma 123Breast Neoplasms 123Lymphoma, Mantle-Cell 117Leukemia, Myeloid, Acute 117Leukemia, Lymphocytic, Chronic, B-Cell 117Lymphoma, B-Cell, Marginal Zone 113Leukemia 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gastrinoma × Sarcoma × Clear all
NCT00049023 2016-06-21

Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors

University of Iowa

Phase 1 Completed
27 enrolled
CNSEndocrineSarcoma

Familial ependymoma, Insulinoma, Adenoma, Islet Cell, Medulloblastoma, Neuroblastoma, Pheochromocytoma, Sarcoma, Gastrinoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Carcinoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡